Resolvins: A Transformative New Class of Immunoregulatory Drugs

Discovered by biomedical researchers at Harvard Medical School, Resolvins are a novel class of immunoregulatory autacoids that resolve inflammation and promote tissue repair.

Our Technology

Our HEALER technology enables the pharmaceutical development of Resolvins and other bioactive lipids as new molecules with enhanced stability, bioavailability, formulation properties, and patent protection.



Novel agonists of inflammation resolution and tissue repair


HEALER™ Platform

Enabling the development of Resolvins as pharmaceutical drugs


Intellectual Property

Long-term composition of matter patent protection

"We are committed to creating innovative products that improve
the lives of patients suffering from autoimmune and inflammatory diseases."

- Frank C. Sciavolino, Ph.D., Founder and Chief Scientific Officer